Uberti-Foppa Caterina Professore associatoMedicinaMED/17 – Malattie infettive
Biografia
Pubblicazioni
Biografia
Caterina Uberti-Foppa, MD, nata a Pianengo (CR), si è laureata in Medicina e Chirurgia nel 1983, e specializzata con lode in Malattie Infettive e Tropicali presso l’Università degli Studi di Milano nel 1987. All’ Istituto Scientifico San Raffaele (Milano, Italia) ricopre il ruolo di Vice Direttore presso la Divisione di Malattie Infettive dal 1991. Caterina Uberti-Foppa è professore di Malattie Infettive presso l’Università “Vita Salute San Raffaele” di Milano sia per il Corso di Laurea Specialistica/Magistrale in Medicina e Chirurgia, sia per la Scuola di Specializzazione in Malattie Infettive. La sua area di competenza include le malattie infettive e tropicali ed in particolare lo studio delle malattie da virus epatotropi in soggetti immunocompromessi. E’ “Group Leader “ clinico dell’ Unità di Studio e Terapia delle Malattie da Virus Epatotropi, unità di ricerca clinica svolta presso la Divisione di Malattie Infettive.
L’unità collabora con networks nazionali ed internazionali (PITER, EuroSIDA, EUROSUPPORT, ICONA, COHERE, Rete Regionale terapia HCV) ed ha ottenuto fondi da ditte farmaceutiche per la conduzione di studi nazionali ed internazionali di fase II-IV e da agenzie nazionali ( ICONA) ed internazionali (EuroSIDA, EUROSUPPORT).
I suoi interessi di ricerca sono principalmente focalizzati sullo studio delle infezioni da virus epatotropi e sulle nuove strategie di trattamento delle epatiti croniche in soggetti HIV positivi. Attualmente la sua ricerca è focalizzata principalmente sulla distribuzione delle resistenze naturali di HCV in soggetti con epatite C e sul ruolo delle varianti di geni predittori di grave steatosi e / o fibrosi epatica in soggetti HIV / HCV co-infetti. Inoltre i suoi interessi di ricerca comprendono l’accuratezza diagnostica dei biomarcatori non invasivi di fibrosi epatica per la diagnosi di cirrosi epatica e lo studio della farmacocinetica dei nuovi farmaci antiretrovirali in combinazione con terapie anti-HCV in pazienti con cirrosi.
E’ membro della Società Italiana di Malattie Infettive e della “International AIDS Society”.
E’ anche consulente in Malattie Infettive in Istituti Scientifici a Milano ( Istituto Neurologico C.Besta, Istituto Nazionale dei Tumori)
Caterina Uberti Foppa è autrice di 101 articoli originali pubblicati su riviste peer-reviewed (PubMed), h-index (gennaio 2017) 15 (Fonte Scopus). E ‘anche autrice di 12 capitoli di libri di Malattie Infettive del corso di laurea in Medicina e della specializzazione in Malattie Infettive.
Pubblicazioni
101- Merli M, Galli L, Marinaro L, Ariaudo A, Messina E, Uberti-Foppa C, Castagna A, D’Avolio A, Lazzarin A, Bonora S, Hasson H. Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis. J Antimicrob Chemother. 2016 Dec 20. pii: dkw492. doi: 10.1093/jac/dkw492.
100- Sagnelli C, Merli M, Uberti-Foppa C, Hasson H, Grandone A, Cirillo G, Salpietro S, Minichini C, Starace M, Messina E, Morelli P, Miraglia Del Giudice E, Lazzarin A, Coppola N, Sagnelli E. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.World J Gastroenterol. 2016 Oct 14;22(38):8509-8518.
99- Merli M, Castagna A, Salpietro S, Gianotti N, Messina E, Poli A, Morsica G, Bagaglio S, Cernuschi M, Bigoloni A, Uberti-Foppa C, Lazzarin A, Hasson H Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients. New Microbiol. 2016 Feb;39(2):110-3. PMID:27196548. IF (2015/2016) 1.784 ; ISSN: 1121-7138
98-Bagaglio S, Andolina A, Merli M, Uberti-Foppa C, Morsica G. Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment.Viruses. 2016 Mar 25;8(4). pii: E91. doi: 10.3390/v8040091.PMID:27023593. IF (2015/2016) 3.353 ; ISSN: 1999-4915
97- Sagnelli C, Merli M, Uberti-Foppa C, Hasson H, Cirillo G, Grandone A, Salpietro S,
Minichini C, Del Giudice EM, Lazzarin A, Sagnelli E, Coppola N. Impact of PNPLA3 variants on
the liver histology of 168 patients with HIV infection and chronic hepatitis C. Clin Microbiol Infect.
2016 Jan 19. pii:S1198-743X(16)00007-0. doi: 10.1016/j.cmi.2015.11.025. [Epub ahead of print]
PubMed PMID: 26806136. IF (2015/2016) 4.575; ISSN: 1198-743X (Print), 1469-0691 (Electronic)
96- Cattaneo D, Puoti M, Sollima S, Moioli C, Foppa CU, Baldelli S, Clementi E, Gervasoni C.J
Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction
with immunosuppressive therapy? Antimicrob Chemother. 2016 Jan 10. pii: dkv466. [Epub ahead
of prin t] PMID: 26755497 . IF (2015/2016) 4.476; ISSN: 0066-4804 (Print), 1098-6596 (Online)
95- Merli M, Messina E, Salpietro S, Lazzarin A, Uberti-Foppa C, Hasson H. Marked
Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)-Coinfected Patients
With Advanced Liver Disease During Anti-HCV Treatment With Direct-Acting
Antiviral Regimens Including Ribavirin. Clin Infect Dis. 2016 Feb 15;62(4):527-8.
doi: 10.1093/cid/civ902. Epub 2015 Oct 27. PubMed PMID: 26508514. IF (2015/2016) 8.736; ISSN: 1058-4838 (Print), 1537-6591 (Electronic)
94- Bagaglio S, Uberti-Foppa C, Di Serio C, Trentini F, Andolina A, Hasson H,
Messina E, Merli M, Porrino L, Lazzarin A, Morsica G. Dynamic of Mixed HCV
Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With
Peg-IFN/Ribavirin. Medicine (Baltimore). 2015 Oct;94(43):e1876. doi:
10.1097/MD.0000000000001876. PubMed PMID: 26512601. IF (2015/2016) 5.723; ISSN: 0025-7974
93- Bagaglio S, Uberti-Foppa C, Messina E, Merli M, Hasson H, Andolina A, Galli A,
Lazzarin A, Morsica G. Distribution of natural resistance to NS3 protease
inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in
genotype 1b of HIV-infected patients. Clin Microbiol Infect. 2015 Dec 17. pii:
S1198-743X(15)01033-2. doi: 10.1016/j.cmi.2015.12.007. [Epub ahead of print]
PubMed PMID: 26706617. IF (2015/2016) 4.575; ISSN: 1198-743X (Print), 1469-0691 (Electronic)
92- Hasson H, Messina E, Merli M, Della Torre L, Morsica G, Bagaglio S, Lazzarin
A, Uberti-Foppa C. Sustained virological response after ten days of triple
anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon
and ribavirin in an HIV/HCV co-infected cirrhotic woman. Int J Infect Dis. 2014
Dec;29:100-2. doi: 10.1016/j.ijid.2014.08.011. Epub 2014 Oct 24. PubMed PMID:
- IF (2014) 1.859; ISSN: 1201-9712
91- Armignacco O, Andreoni M, Sagnelli E, Puoti M, Bruno R, Gaeta GB, Perno CF,
Santantonio TA, Bonfanti P, Bonora S, Borderi M, Castagna A, d’Arminio Monforte
A, De Luca A, Grossi P, Guaraldi G, Maggiolo F, Mussini C, Sagnelli C, Tavio M,
Torti C, Uberti-Foppa C, Andreoni M, Angarano G, Antinori A, Armignacco O, Carosi
G, Chirianni A, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Sagnelli E,
Taliani G. Recommendations for the use of hepatitis C virus protease inhibitors
for the treatment of chronic hepatitis C in HIV-infected persons. A position
paper of the Italian Association for the Study of Infectious and Tropical
Disease. New Microbiol. 2014 Oct;37(4):423-38. Epub 2014 Oct 1. PubMed PMID:
- IF (2014) 1.784 ; ISSN: 1121-7138
90- Cogliati M, Zamfirova RR, Tortorano AM, Viviani MA; Fimua Cryptococcosis Network.Molecular epidemiology of Italian clinical Cryptococcus neoformans var. grubii isolates.Med Mycol. 2013 Jul;51(5):499-506. doi: 10.3109/13693786.2012.751642. Epub 2013 Jan 4.PMID: 23286351. IF (2013) 2.261 ; ISSN: ISSN: 1369-3786 (Print), 1460-2709 (Online)
89- Sagnelli C, Uberti-Foppa C, Galli L, Pasquale G, Coppola N, Albarello L,Doglioni C, Lazzarin A, Sagnelli E. Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients. Braz J Infect Dis. 2014 Mar-Apr;18(2):164-9. doi: 10.1016/j.bjid.2013.06.005. Epub 2013 Oct 25. PubMed PMID: 24650995. IF (2013) 1.299; ISSN: 1413-8670
88- Platteau T, Müller MC, Nideröst S, Csepe P, Dedes N, Apers L, Schrooten W,
Nöstlinger C; Eurosupport 5 Study Group. Patients’ satisfaction with sexual and
reproductive health services delivered in HIV clinics across European regions.
Cent Eur J Public Health. 2013 Sep;21(3):123-7.;PubMed PMID: 24344532. IF (2013) 0.798; ISSN: 1210-7778
87- Sagnelli C, Uberti-Foppa C, Pasquale G, De Pascalis S, Coppola N, Albarello L,
Doglioni C, Lazzarin A, Sagnelli E. Factors influencing liver fibrosis and
necroinflammation in HIV/HCV coinfection and HCV monoinfection. Infection. 2013
Oct;41(5):959-67. doi: 10.1007/s15010-013-0502-3. Epub 2013 Jul 10. PubMed PMID:
- IF (2013) 2.864; ISSN: 0300-8126 (Print), 1439-0973 (Online)
86- Hasson H, Merli M, Galli L, Gallotta G, Carbone A, Messina E, Bagaglio S,
Morsica G, Salpietro S, Castagna A, Lazzarin A, Uberti-Foppa C. Non-invasive
fibrosis biomarkers – APRI and Forns – are associated with liver stiffness in
HIV-monoinfected patients receiving antiretroviral drugs. Liver Int. 2013
Aug;33(7):1113-20. doi: 10.1111/liv.12159. Epub 2013 Mar 28. PubMed PMID:
23534616 . IF (2013) 4.412; ISSN: 1478-3223 (Print), 1478-3231 (Electronic)
85- Brombin C, Diomede L, Tudor D, Drillet AS, Pastori C, Poli E, Riva A,
Uberti-Foppa C, Galli M, Di Serio C, Bomsel M, Lopalco L. A nonparametric
procedure for defining a new humoral immunologic profile in a pilot study on HIV
infected patients. PLoS One. 2013;8(3):e58768. doi: 10.1371/journal.pone.0058768.
Epub 2013 Mar 22. PubMed PMID: 23533590; PubMed Central PMCID: PMC3606389. IF (2013) 3.534; ISSN: 1932-6203.
84- Bagaglio S, Messina E, Uberti-Foppa C, Merli M, Torre LD, Lazzarin A, Hasson
H, Morsica G. Reversion of naturally occurring high-level resistance mutations to
NS3 protease inhibitors in two treatment-naive individuals infected with
hepatitis C virus. J Antimicrob Chemother. 2013 Jun;68(6):1448-50. doi:
10.1093/jac/dkt019. Epub 2013 Feb 6. PubMed PMID: 23390206. IF (2013) 5.439; ISSN: 0305-7453 (Print), 1460-2091 (Electronic)
83- Nöstlinger C, Desjardins F, Dec J, Platteau T, Hasker E; Eurosupport V Study Group. Child desire in women and men living with HIV attending HIV outpatient clinics: evidence from a European multicentre study. Eur J Contracept Reprod Health Care. 2013 Aug;18(4):251-63. doi: 10.3109/13625187.2013.801072. Epub 2013 Jun 5. PMID: 2373888. IF (2013) 1,835; ISSN: 1362-5187 (Print), 1473-0782 (Online)
82- Hasson H, Galli L, Gallotta G, Neri V, Blanc P, D’Annunzio M, Morsica G,
Sollima S, Merli M, Lazzarin A, Uberti-Foppa C. HAART simplification with
lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV
treatment: a randomised pilot study (KaMon study). New Microbiol. 2012.
Oct;35(4):469-74. Epub 2012 Oct 1. PubMed PMID: 23109014. IF (2012) 1.667 ; ISSN: 1121-7138
81- Schiavini M, Angeli E, Mainini A, Uberti-Foppa C, Zerbi P, Sagnelli C,
Cargnel A, Vago G, Duca PG, Giorgi R, Rizzardini G, Gubertini G. Fibrosis
progression in paired liver biopsies from HIV/HCV co-infected patients. Hepat
Mon. 2011 Jul 1;11(7):525-31. PubMed PMID: 22706343; PubMed Central PMCID:
PMC3212761. IF (2011) 2.19 ; ISSN: 1735-143X (Print), 1735-3408 (Online)
80- Miro JM, Manzardo C, Mussini C, Johnson M, d’Arminio Monforte A, Antinori A,
Gill MJ, Sighinolfi L, Uberti-Foppa C, Borghi V, Sabin C; Late Presenters
Investigators. Survival outcomes and effect of early vs. deferred cART among
HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort
analysis. PLoS One. 2011;6(10):e26009. doi: 10.1371/journal.pone.0026009. Epub
2011 Oct 17. PubMed PMID: 22043301; PubMed Central PMCID: PMC3197144. IF (2011) 4.092; ISSN: 1932-6203.
79- Nideröst S, Gredig D, Roulin C, Rickenbach M; Swiss Hiv Cohort Study; Eurosupport 5 Study Group. Predictors of HIV-protection behaviour in HIV-positive men who have sex with casual male partners: a test of the explanatory power of an extended Information-Motivation-Behavioural Skills model. AIDS Care. 2011 Jul;23(7):908-19. doi: 10.1080/09540121.2010.538661. IF (2011) 0. ISSN: 0954-0121
78- Nöstlinger C, Nideröst S, Platteau T, Müller MC, Staneková D, Gredig D,
Roulin C, Rickenbach M, Colebunders R; Swiss HIV Cohort Study and The Eurosupport
Study Group. Sexual protection behavior in HIV-positive gay men: testing a
modified information-motivation-behavioral skills model. Arch Sex Behav. 2011
Aug;40(4):817-27. doi: 10.1007/s10508-010-9682-4. Epub 2010 Sep 28. PubMed PMID:
- IF (2011) 0; ISSN: 0004-0002
77- Sagnelli C, Uberti-Foppa C, Galli L, Pasquale G, Coppola N, Albarello L,
Masiello A, Doglioni C, Lazzarin A, Sagnelli E. Liver histology in HIV/hepatitis
C-coinfected and HCV-monoinfected patients with persistently normal alanine
aminotransferases. J Acquir Immune Defic Syndr. 2010 May 1;54(1):107-8. doi:
10.1097/QAI.0b013e3181cf4d8b. Erratum in: J Acquir Immune Defic Syndr. 2010 Jul
1;54(3):338. Galli, Laura [added]. PubMed PMID: 20418725. IF (2010) 3.39; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)
76- Morsica G, Bianchi G, Bagaglio S, Conte C, Salpietro S, Porrino L, Uberti-Foppa C. Hepatic safety profile of darunavir with low-dose ritonavir (DRV/r) in HIV/HCV coinfected and HIV monoinfected patients.New Microbiol. 2011 Jul;34(3):317-21. Epub 2011 Jul 30. PMID:21811753. IF (2011) 1 ; ISSN: 1121-7138
75- Bagaglio S, Bianchi G, Danise A, Porrino L, Uberti-Foppa C, Lazzarin A, Castagna A, Morsica G.Longitudinal evaluation of occult hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption. Infection. 2011 Apr;39(2):121-6. doi: 10.1007/s15010-011-0093-9. Epub 2011 Mar 22. PMID:21424854. IF (2011) 2.659; ISSN: 0300-8126 (Print), 1439-0973 (Online)
74- Nöstlinger C, Nideröst S, Gredig D, Platteau T, Gordillo V, Roulin C, Rickenbach M, Dias SF, Rojas D; Swiss HIV Cohort Study; Eurosupport5 Study Group. Condom use with steady partners among heterosexual people living with HIV in Europe: testing the information-motivation-behavioral skills model. AIDS Patient Care STDS. 2010 Dec;24(12):771-80. doi: 10.1089/apc.2010.0246. Epub 2010 Nov 22. IF (2010) 2.333; ISSN: 1087-2914
73- Bagaglio S, Albarello L, Biswas P, Uberti-Foppa C, Fortis C, Morsica G. Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report. J Med Case Rep. 2009 Nov 9;3:110. doi:10.1186/1752-1947-3-110. PubMed PMID: 19946588; PubMed Central PMCID: PMC2783051. IF 2009 0, ISSN: 1752-1947.
72- Angeli E, Mainini A, Cargnel A, Uberti-Foppa C, Orani A, Carbone R, Andreoni
M, Schiavini M, Giorgi R, Rizzardini G, Gubertini G; ICoS-2 Group. Predictability
of sustained virological response to pegylated interferon alpha-2b Plus ribavirin
therapy by week-8 viral response in HIV-positive patients with chronic hepatitis
C virus infection. Curr HIV Res. 2009 Jul;7(4):447-55. PubMed PMID: 19601782. IF (2009) 1.978; ISSN: 1570-162X (Print), 1873-4251 (Online)
71- Morsica G, Bagaglio S, Cicconi P, Capobianchi MR, Pellizzer G, Caramello P,
Orani A, Moioli C, Rizzardini G, Uberti-Foppa C, Puoti M, Monforte AD; Hepa
I.C.o.N.A the Icona Foundation Study Groups. Viral interference between hepatitis
B, C, and D viruses in dual and triple infections in HIV-positive patients. J
Acquir Immune Defic Syndr. 2009 Aug 15;51(5):574-81. doi: 10.1097/QAI.0b013e3181add592. PubMed PMID: 19590432.IF (2009) 4.207; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)
70- Gordillo V, Fekete E, Platteau T, Antoni MH, Schneiderman N, Nöstlinger C;
Eurosupport Study Group. Emotional support and gender in people living with HIV:
effects on psychological well-being. J Behav Med. 2009 Dec;32(6):523-31. doi:
10.1007/s10865-009-9222-7. PubMed PMID: 19543823. .IF (2009) 0; ISSN: 0160-7715
69- Morsica G, Bagaglio S, Uberti-Foppa C, Galli L, Lazzarin A. Detection of
hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in
HIV/HCV-coinfected individuals treated with antiretroviral therapy. J Acquir
Immune Defic Syndr. 2009 May 1;51(1):106-8. doi: 10.1097/QAI.0b013e3181a02fda.
PubMed PMID: 19390331. IF (2009) 4.207; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)
68- Hirbod T, Kaldensjö T, Lopalco L, Klareskog E, Andersson S, Uberti-Foppa C,
Ferrari D, Manghi M, Andersson J, Loré K, Broliden K. Abundant and superficial
expression of C-type lectin receptors in ectocervix of women at risk of HIV
infection. J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):239-47. doi:
10.1097/QAI.0b013e3181a74f89. PubMed PMID: 19363450. IF (2009) 4.207; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)
67- Mussini C, Manzardo C, Johnson M, Monforte Ad, Uberti-Foppa C, Antinori A,
Gill MJ, Sighinolfi L, Borghi V, Lazzarin A, Miró JM, Sabin C; Late Presenter
Investigators. Patients presenting with AIDS in the HAART era: a collaborative
cohort analysis. AIDS. 2008 Nov 30;22(18):2461-9. doi:
10.1097/QAD.0b013e328314b5f1. PubMed PMID: 19005269. IF (2008) 5.46; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)
66- Valentini LG, Casali C, Chatenoud L, Chiaffarino F, Uberti-Foppa C, Broggi G.
Surgical site infections after elective neurosurgery: a survey of 1747 patients.
Neurosurgery. 2008 Jan;62(1):88-95; discussion 95-6. doi:
10.1227/01.NEU.0000311065.95496.C5. PubMed PMID: 18300895. IF (2008) 3.398; ISSN: 0148-396X (Print), 1524-4040 (Online)
65- Spagnuolo V, Gentilini G, De Bona A, Galli L, Uberti-Foppa C, Soldarini A,
Dorigatti F, Seminari E. Liver function parameters in HIV/HCV co-infected
patients treated with amprenavir and ritonavir and correlation with plasma
levels. New Microbiol. 2007 Jul;30(3):279-82. PubMed PMID: 17802909. IF (2007) 0.956 ; ISSN: 1121-7138
64- De Bona A, Galli L, Gallotta G, Guzzo A, Alagna L, Lazzarin A, Uberti-Foppa
- C. Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to
anti-HCV therapy. New Microbiol. 2007 Jul;30(3):259-64. PubMed PMID: 17802905.
63- Fluur C, Rethi B, Thang PH, Vivar N, Mowafi F, Lopalco L, Foppa CU, Karlsson A, Tambussi G, Chiodi F. Relationship between serum IL-7 concentrations and lymphopenia upon different levels of HIV immune control. AIDS. 2007 May 11;21(8):1048-50. PMID: 17457102 IF (2007) 5.842; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)
62- Seminari E, De Bona A, Gentilini G, Galli L, Schira G, Gianotti N,
Uberti-Foppa C, Soldarini A, Dorigatti F, Lazzarin A, Castagna A. Amprenavir and
ritonavir plasma concentrations in HIV-infected patients treated with
fosamprenavir/ritonavir with various degrees of liver impairment. J Antimicrob
Chemother. 2007 Oct;60(4):831-6. Epub 2007 Aug 7. PubMed PMID: 17684056. IF (2007) 4.038; ISSN: 0305-7453 (Print), 1460-2091 (Electronic)
61- Hirbod T, Nilsson J, Andersson S, Uberti-Foppa C, Ferrari D, Manghi M,
Andersson J, Lopalco L, Broliden K. Upregulation of interferon-alpha and RANTES
in the cervix of HIV-1-seronegative women with high-risk behavior. J Acquir
Immune Defic Syndr. 2006 Oct 1;43(2):137-43. PubMed PMID: 16940859. IF (2006) 3.806; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)
60- Sitia G, De Bona A, Bagaglio S, Galli L, Paties CT, Uberti-Foppa C, Guidotti
LG, Lazzarin A, Morsica G. Naive HIV/HCV-coinfected patients have higher
intrahepatic pro-inflammatory cytokines than coinfected patients treated with
antiretroviral therapy. Antivir Ther. 2006;11(3):385-9. PubMed PMID: 16759056. IF (2006) 4.892; ISSN: 1359-6535 (Print), 2040-2058 (Electronic)
59- Lillo FB, Uberti-Foppa C. Human papillomavirus viral load: a possible marker
for cervical disease in HIV-infected women. J Antimicrob Chemother. 2006
May;57(5):810-4. Epub 2006 Mar 23. PubMed PMID: 16556637. IF (2006) 3.891; ISSN: 0305-7453 (Print), 1460-2091 (Electronic)
58- Pastori C, Weiser B, Barassi C, Uberti-Foppa C, Ghezzi S, Longhi R, Calori G,
Burger H, Kemal K, Poli G, Lazzarin A, Lopalco L. Long-lasting CCR5
internalization by antibodies in a subset of long-term nonprogressors: a possible
protective effect against disease progression. Blood. 2006 Jun
15;107(12):4825-33. Epub 2006 Mar 7. PubMed PMID: 16522810; PubMed Central PMCID:
PMC1895813. IF (2006) 10.370; ISSN: 0006-4971 (Print), 1528-0020 (Electronic)
57- Uberti-Foppa C, De Bona A, Galli L, Sitia G, Gallotta G, Sagnelli C, Paties
C, Lazzarin A. Liver fibrosis in HIV-positive patients with hepatitis C virus:
role of persistently normal alanine aminotransferase levels. J Acquir Immune
Defic Syndr. 2006 Jan 1;41(1):63-7. PubMed PMID: 16340475. IF (2006) 3.946; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)
56- Lillo FB, Lodini S, Ferrari D, Stayton C, Taccagni G, Galli L, Lazzarin A,
Uberti-Foppa C. Determination of human papillomavirus (HPV) load and type in
high-grade cervical lesions surgically resected from HIV-infected women during
follow-up of HPV infection. Clin Infect Dis. 2005 Feb 1;40(3):451-7. Epub 2005
Jan 7. PubMed PMID: 15668870. IF (2005) 6.510; ISSN: 1058-4838 (Print), 1537-6591 (Electronic)
55- Bossolasco S, Gaiera G, Olchini D, Gulletta M, Martello L, Bestetti A, Bossi
L, Germagnoli L, Lazzarin A, Uberti-Foppa C, Cinque P. Real-time PCR assay for
clinical management of human immunodeficiency virus-infected patients with
visceral leishmaniasis. J Clin Microbiol. 2003 Nov;41(11):5080-4. Erratum in: J
Clin Microbiol. 2004 Apr;42(4):1858. PubMed PMID: 14605142; PubMed Central PMCID:
PMC262523. IF (2004) 3.439; ISSN: 0095-1137 (Print), 1098-660X (Electronic)
54- Bucceri AM, Somigliana E, Matrone R, Uberti-Foppa C, Viganò P, Vignali M.
Discontinuing combination antiretroviral therapy during the first trimester of
pregnancy: insights from plasma human immunodeficiency virus-1 RNA viral load and
CD4 cell count. Am J Obstet Gynecol. 2003 Aug;189(2):545-51. PubMed PMID:
- IF (2003) 2.518; ISSN: 0002-9378 (Print), 1097-6868 (Online)
53- De Bona A, Sitia G, Uberti-Foppa C, Galli L, Ciuffreda D, Gallotta G, Paties
C, Lazzarin A. Impact of HAART on liver histology of HIV/HCV coinfected patients.
J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):195-7. PubMed PMID: 14518723.
- IF (2003) 0.748; ISSN: 0393-974X
52- Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori
G, Lazzarin A, Clementi M. Characterization of GBV-C infection in HIV-1 infected
patients. J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):191-4. PubMed PMID:
- IF (2003) 0.748; ISSN: 0393-974X
51- Uberti-Foppa C, Ferrari D, Lodini S, Reina S, Ameglio F, Grasso MA, Gallotta
G, Ferrari A, Taccagni G, Lazzarin A, Lillo FB. Long-term effect of highly active
antiretroviral therapy on cervical lesions in HIV-positive women. AIDS. 2003 Sep
26;17(14):2136-8. PubMed PMID: 14502023. IF (2003) 5.521; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)
50- Uberti-Foppa C, De Bona A, Morsica G, Galli L, Gallotta G, Boeri E, Lazzarin
- Pretreatment of chronic active hepatitis C in patients coinfected with HIV and
hepatitis C virus reduces the hepatotoxicity associated with subsequent
antiretroviral therapy. J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):146-52.
PubMed PMID: 12794546. IF (2003) 3.681; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)
49- Kirk O, Reiss P, Uberti-Foppa C, Bickel M, Gerstoft J, Pradier C, Wit FW,
Ledergerber B, Lundgren JD, Furrer H; European HIV Cohorts. Safe interruption of
maintenance therapy against previous infection with four common HIV-associated
opportunistic pathogens during potent antiretroviral therapy. Ann Intern Med.
2002 Aug 20;137(4):239-50. PubMed PMID: 12186514. IF (2002) 11.414; ISSN: 0003-4819 (Print), 1539-3704 (Electronic)
48- European Confederation of Medical Mycology (ECMM) prospective survey of cryptococcosis: report from Italy.[No authors listed] Med Mycol. 2002 Oct;40(5):507-17.PMID:12462531. IF (2002) 2.067; ISSN: 1369-3786 (Print), 1460-2709 (Online)
47- Pastori C, Barassi C, Lillo F, Longhi R, Capiluppi B, Nozza S, Galli A,
Uberti-Foppa C, Lazzarin A, Tambussi G, Lopalco L. The effect of HAART on humoral
immune response in primary HIV-1 infected patients. J Biol Regul Homeost Agents.
2002 Jan-Mar;16(1):9-17. PubMed PMID: 12003182. IF (2002) 0.603; ISSN: 0393-974X
46- Moretti F, Uberti-Foppa C, Quiros-Roldan E, Fanti L, Lillo F, Lazzarin A.
Oesophagobronchial fistula caused by varicella zoster virus in a patient with
AIDS: a unique case. J Clin Pathol. 2002 May;55(5):397-8. PubMed PMID: 11986352;
PubMed Central PMCID: PMC1769657. IF (2002) 2.549; ISSN: 0021-9746 (Print), 1472-4146 (Online)
45- Matteucci P, Magni M, Di Nicola M, Carlo-Stella C, Uberti C, Gianni AM Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody. Blood. 2002 Aug 1;100(3):1104-5. No abstract available. PMID: 12150156 IF (2002) 9.631; ISSN: 0006-4971 (Print), 1528-0020 (Electronic)
44- Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E,
Taccagni G, Lazzarin A, Uberti-Foppa C. Human papillomavirus infection and
associated cervical disease in human immunodeficiency virus-infected women:
effect of highly active antiretroviral therapy. J Infect Dis. 2001 Sep
1;184(5):547-51. Epub 2001 Aug 9. PubMed PMID: 11494160. IF (2001) 4.910; ISSN: 0022-1899 (Print), 1537-6613 (Online)
43- Sitia G, Cella D, De Mitri MS, Novati R, Foppa CU, Perackis K, Bianchi C, Lazzarin A, Morsica G Evolution of the E2 region of hepatitis C virus in an infant infected by mother-to-infant transmission. J Med Virol. 2001 Aug;64(4):476-81. PMID: 11468732 IF (2001) 2.881; ISSN: 0146-6615 (Print), 1096-9071 (Online)
42- Ledergerber B, Mocroft A, Reiss P, Furrer H, Kirk O, Bickel M, Uberti-Foppa
C, Pradier C, D’Arminio Monforte A, Schneider MM, Lundgren JD; Eight European
Study Groups. Discontinuation of secondary prophylaxis against Pneumocystis
carinii pneumonia in patients with HIV infection who have a response to
antiretroviral therapy. Eight European Study Groups. N Engl J Med. 2001 Jan
18;344(3):168-74. PubMed PMID: 11188837. IF (2001) 29.065; ISSN: 0028-4793 (Print), 1533-4406 (Electronic)
41- Gianotti N, Uberti-Foppa C, Boeri E, Marinelli M, Tambussi G, Finazzi R,
Lazzarin A. Hepatitis B surface antigen clearance and appearance of antibodies
against hepatitis B surface antigen after treatment with recombinant interleukin
2 in a human immunodeficiency virus-infected patient. Hepatology. 2000
Dec;32(6):1409-10. PubMed PMID: 11186868. IF (2000) 7.304; ISSN: 0270-9139 (Print), 1527-3350 (Electronic)
40- Morsica G, De Bona A, Foppa CU, Sitia G, Finazzi R, Lazzarin A. Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment. AIDS. 2000 Jul 28;14(11):1656-8. No abstract available. PMID: 10983654 IF (2000) 8.018; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)
39- Uberti-Foppa C, De Bona A, Morsica G, Guffanti M, Gianotti N, Boeri E,
Lazzarin A. Recombinant interleukin-2 for treatment of HIV reduces hepatitis C
viral load in coinfected patients. AIDS. 1999 Jan 14;13(1):140-1. PubMed PMID:
- IF (1999) 6.931; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)
38- Uberti-Foppa C, Origoni M, Maillard M, Ferrari D, Ciuffreda D, Mastrorilli E,
Lazzarin A, Lillo F. Evaluation of the detection of human papillomavirus
genotypes in cervical specimens by hybrid capture as screening for precancerous
lesions in HIV-positive women. J Med Virol. 1998 Oct;56(2):133-7. PubMed PMID: 9746069. IF (1998) 2.594; ISSN: 0146-6615 (Print), 1096-9071 (Online)
37- Uberti-Foppa C, Lillo F, Terreni MR, Puglisi A, Guffanti M, Gianotti N,
Lazzarin A. Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus
culture from BAL fluid and correlation with lung disease. Chest. 1998
Apr;113(4):919-23. PubMed PMID: 9554626. IF (1998) 2.246; ISSN: 0012-3692 (Print), 1931-3543 (Electronic)
36- Uberti-Foppa C, Finazzi R, De Bona A. Recombinant interferon-alpha therapy
and meno-metrorrhagia. Br J Obstet Gynaecol. 1998 Mar;105(3):367-8. PubMed PMID:
9533004.if (1998) 2.299; ISSN: 1470-0328 (Print)-1471-0528 (Electronic)
35- Morsica G, Bernardi MT, Novati R, Uberti Foppa C, Castagna A, Lazzarin A.
Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of
HIV-infected patients. J Med Virol. 1997 Nov;53(3):252-4. PubMed PMID: 9365891. IF (1997) 3.188; ISSN: 0146-6615 (Print), 1096-9071 (Online)
34- Bettini P, Boeri E, Lillo F, Abecasis C, Farma E, Crociati E, Uberti-Foppa C,
Varnier OE. HIV-1 RNA quantification by one-tube quantitative NASBA in
HIV-infected patients. AIDS. 1996 Dec;10(14):1735-7. PubMed PMID: 8970695. IF (1996) 5.983; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)
33- Uberti-Foppa C, Fumagalli L, Gianotti N, Viviani AM, Vaiani R, Gieho E. First
case of osteomyelitis due to Phialophora richardsiae in a patient with HIV
infection. AIDS. 1995 Aug;9(8):975-6. PubMed PMID: 7576338. IF (1995) 4.878; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)
32- Gianotti N, Finazzi R, Uberti Foppa C, Danise A, Migone T, Lazzarin A. The
thymic hormones in the treatment of immune deficiency related to HIV infection.
Pharmacol Res. 1992 Sep;26 Suppl 2:62-3. PubMed PMID: 1409328. IF (1992) 0.702; ISSN: 1043-6618 (Print), 1096-1186 (Online)
31- Lazzarin A, Castagna A, Cavalli G, Amprimo MC, Vaj M, Parravicini CL, Costanzi G, Ronchi P, Foppa CU, Moroni M, Turconi R.Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement. J Clin Lab Immunol. 1992;38(4):175-86. PMID: 11270518
30– Foppa CU, Bini T, Gregis G, Lazzarin A, Esposito R, Moroni M A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine. Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):187-9. IF (1991) 2.259; PMID: 2060526 ISSN: 0934-9723 (Print), 1435-4373 (Online)
29- Esposito R, Castagna A, Uberti Foppa C. Maintenance therapy of oropharyngeal
candidiasis in HIV-infected patients with fluconazole. AIDS. 1990
Oct;4(10):1033-4. PubMed PMID: 2261119. IF (1990) 4.407; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)
28- Rezza G, Lazzarin A, Uberti-Foppa C, Tumbarello M, Menniti-Ippolito F,
Pezzotti P, Titti F, Verani P. Risk behaviour and HTLV-1 seropositivity in
injecting drug users. Br J Addict. 1990 May;85(5):686-7. PubMed PMID: 2354287.
27- Esposito R, Uberti Foppa C, Cernuschi M. Treatment of invasive fungal
infections in immunocompromised patients with fluconazole. J Chemother. 1989
Jul;1(4 Suppl):925-6. PubMed PMID: 16312707. IF (2015/2016) 1.604; ISSN: 1120-009X (Print), 1973-9478 (Online)
26- Esposito R, Foppa CU, Antinori S. Fluconazole for cryptococcal meningitis. Ann Intern Med. 1989 Jan 15;110(2):170. No abstract available. PMID: 2535777 IF (2015/2016) 16.440; ISSN: 0003-4819 (Print), 1539-3704 (Electronic)
25- Esposito R, Uberti Foppa C. Nosography and therapy of opportunistic
infections of the central nervous system in AIDS patients. J Chemother. 1989
Jul;1(4 Suppl):923-4. PubMed PMID: 16312706. . IF (2015/2016) 1.604; ISSN: 1120-009X (Print), 1973-9478 (Online).
24- d’Arminio Monforte A, Novati R, Marchisio P, Zanchetta N, Uberti-Foppa C,
Tornaghi R, Massironi E, Lazzarin A, Principi N. Early diagnosis of HIV infection
in infants. AIDS. 1989 Jun;3(6):391-5. PubMed PMID: 2502154. IF (2015/2016) 4.407; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)
23- Vago L, Antonacci MC, Cristina S, Parravicini C, Lazzarin A, Moroni M, Negri
C, Uberti-Foppa C, Musicco M, Costanzi G. Morphogenesis, evolution and prognostic
significance of lymphatic tissue lesions in HIV infection. Appl Pathol.
1989;7(5):298-309. PubMed PMID: 2635617.
22- Galli M, Lazzarin A, Saracco A, Balotta C, Castagna A, Negri C, Ridolfo AL,
Uberti-Foppa C, Corbellino M, Moroni M. Clinical and immunological aspects of HIV
infection in drug addicts. Clin Immunol Immunopathol. 1989 Jan;50(1 Pt
2):S166-76. PubMed PMID: 2562942.
21- Bedarida G, Crocchiolo P, Cambié G, D’Agostino F, Uberti Foppa C, Berto E,
Grisi ME, Arcidiacono I, Ronsivalle MG, Pasquali M, et al. HIV-IgM serology.
Infection. 1988 Sep-Oct;16(5):301-2. PubMed PMID: 3215691. IF (2015/2016) 2.618; ISSN: 0300-8126 (Print), 1439-0973 (Online)
20- Franzetti F, Cavalli G, Foppa CU, Amprimo MC, Gaido P, Lazzarin A.Raised serum beta 2 microglobulin levels in different stages of human immunodeficiency virus infection. J Clin Lab Immunol. 1988 Nov;27(3):133-7. Review. PMID: 3073225
19- Tagliabue A, Nencioni L, Mantovani A, Lazzarin A, Villa L, Romano M, Rossini S, Foppa CU, Fanetti G, Masello LC, et al Impairment of in vitro natural antibacterial activity in HIV-infected patients. J Immunol. 1988 Oct 15;141(8):2607-11. PMID: 3262664. IF (2015/2016) 4.922; ISSN: 0022-1767 (Print), 1550-6606 (Online)
18- Alessi E, Cusini M, Zerboni R, Cavicchini S, Uberti-Foppa C, Galli M, Moroni
- Unusual varicella zoster virus infection in patients with the acquired
immunodeficiency syndrome. Arch Dermatol. 1988 Jul;124(7):1011-3. PubMed PMID:
- IF (2015/2016) 4.789; ISSN: 0003-987X (Print), 0096-5359 (Online)
17- Scorza Smeraldi R, Fabio G, Lazzarin A, Eisera N, Uberti Foppa C, Moroni M,
Zanussi C. HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor
for Italian HIV-infected intravenous drug addicts. Hum Immunol. 1988
Jun;22(2):73-9. PubMed PMID: 3262099. IF (2015/2016) 2.138; ISSN: 0198-8859
16- Lazzarin A, Uberti Foppa C, Crocchiolo P, Verani P, Varnier O, Salvi D. Risk
of HIV-related diseases in heterosexuals importing infection from Zaire. Eur J
Epidemiol. 1988 Mar;4(1):131-2. PubMed PMID: 3356231. IF (2015/2016) 5.339; ISSN: 0393-2990 (Print), 1573-7284 (Online)
15- Titti F, Lazzarin A, Costigliola P, Oliva C, Nicoletti L, Negri C, Ricchi E,
Donati G, Uberti-Foppa C, Re MC, et al. Human immunodeficiency virus (HIV)
seropositivity in intravenous (i.v.) drug abusers in three cities of Italy:
possible natural history of HIV infection in i.v. drug addicts in Italy. J Med
Virol. 1987 Nov;23(3):241-8. PubMed PMID: 3430144. IF (2015/2016) 2.347; ISSN: 0146-6615 (Print), 1096-9071 (Online)
14- Procaccia S, Lazzarin A, Colucci A, Gasparini A, Forcellini P, Lanzanova D, Foppa CU, Novati R, Zanussi C IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities. Clin Exp Immunol. 1987 Feb;67(2):236-44. PMID: 3608224. IF (2015/2016) 3.037; ISSN: 0009-9104 (Print), 1365-2249 (Online)
13- Lazzarin A, Uberti Foppa C, Negri C, Orlando G, Re T, Moroni M.
Epidemiological aspects of human immunodeficiency virus infection in Milan.
Chemioterapia. 1987 Jun;6(2 Suppl):632-3. PubMed PMID: 3509510.
12- Uberti Foppa C, Zanchetta N, Nardi G, Re T, Orlando G, Cinque P, Lazzarin A.
Risk of HIV infection in recipients of blood and blood products. Chemioterapia.
1987 Jun;6(2 Suppl):633-4. PubMed PMID: 3334654.
11- Uberti Foppa C, Orando G, Lazzarin A, Zanchetta N, Piero Nardi G, Bedarida G.
Risk of human immunodeficiency virus infection in multiple transfused patients.
Transfusion. 1987 Mar-Apr;27(2):217. PubMed PMID: 3824486. IF (2015/2016) 3.225; ISSN: 0041-1132 (Print), 1537-2995 (Online)
10- Barcellini W, Meroni PL, Frasca D, Sguotti C, Borghi MO, Uberti-Foppa C,
Buzzetti P, Lazzarin A, Doria G, Moroni M, et al. Effect of subcutaneous
thymopentin treatment in drug addicts with persistent generalized
lymphadenopathy. Clin Exp Immunol. 1987 Mar;67(3):537-43. PubMed PMID: 3301099;
PubMed Central PMCID: PMC1542610. IF (2015/2016) 3.037; ISSN: 0009-9104 (Print), 1365-2249 (Online)
9- Uberti Foppa C, Franzetti F, Negri C, Novati R, Cinque P, Privitera G,
Parente F, Crocchiolo P, Lazzarin A. Role of PMN’s candidicidal activity in the
pathogenesis of AIDS-related systemic candidiases. Boll Ist Sieroter Milan.
1987;66(6):471-8. PubMed PMID: 3502581.
8- Lazzarin A, Crocchiolo P, Galli M, Uberti Foppa C, Caredda F, Re T, Moroni M.
Milan as possible starting point of LAV/HTLV III epidemic among Italian drug
addicts. Boll Ist Sieroter Milan. 1987;66(1):9-13. PubMed PMID: 3304347.
7- Lazzarin A, Barcellini W, Uberti Foppa C, Borghi MO, Franzetti R, Cinque P,
Moroni M. Experiences with immunomodulant agents in HIV infections. Acta
Haematol. 1987;78 Suppl 1:84-90. PubMed PMID: 3124453. IF (2015/2016) 1.116; ISSN: 0001-5792 (Print), 1421-9662 (Online)
6- Lazzarin A, Uberti Foppa C, Galli M, Mantovani A, Poli G, Franzetti F, Nóvati
- Impairment of polymorphonuclear leucocyte function in patients with acquired
immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol.1986 Jul;65(1):105-11. PubMed PMID: 3791696; PubMed Central PMCID: PMC1542272.
IF (2015/2016) 3.037; ISSN: 0009-9104 (Print), 1365-2249 (Online)
5- Lazzarin A, Luerti M, Capsoni F, Galli M, Uberti-Foppa C, Zavattini G,
Corbella E. A study of cellular immunity in newborns after prevention of
respiratory distress syndrome (RDS). Int J Tissue React. 1986;8(2):157-65. PubMed
PMID: 3700005.
4- Lazzarin A, Orlando G, Privitera G, Crocchiolo P, Esposito R, Uberti Foppa C,
Castagna A, Irato L, Moroni M. Clinical and epidemiological aspects of the first
50 cases of AIDS in Milan. Boll Ist Sieroter Milan. 1986;65(6):481-6. PubMed
PMID: 3580141.
3- Lazzarin A, Uberti-Foppa C, Galli M, Crocchiolo P, Moroni M. Pulmonary
candidiasis in a heroin addict: some remarks on its aetiology and pathogenesis.
Br J Addict. 1985 Mar;80(1):103-4. PubMed PMID: 3856443.
2- Lazzarin A, Mella L, Trombini M, Uberti-Foppa C, Franzetti F, Mazzoni G,
Galli M. Immunological status in heroin addicts: effects of methadone maintenance
treatment. Drug Alcohol Depend. 1984 Mar;13(2):117-23. PubMed PMID: 6609805.
IF (2015/2016) 3.423; ISSN: 0376-8716.
1- Lazzarin A, Luerti M, Uberti-Foppa C, Zavattini G, Rossi A, Tornaghi R.
Polymorphonuclear leucocytes functions from premature infants after prevention of
respiratory distress syndrome with betamethasone and ambroxol. Biol Res Pregnancy
Perinatol. 1984;5(3):130-4. PubMed PMID: 6478010.
CAPITOLI DI LIBRI
12-C. Uberti-Foppa, G.Gaiera, R.Novati. Infezioni Sistemiche. In: Claudio Rugarli. Medicina Interna Sistematica. VII a ed. Masson; 2015, p 2021-2067. ISBN: 9788821431098
11-A.Castagna, R.Novati, G.Tambussi, C. Uberti-Foppa. Infezioni in Situazioni Particolari. In: Claudio Rugarli. Medicina Interna Sistematica. VII a ed. Masson; 2089-2116. ISBN: 9788821431098
10-Esposito R., Uberti-Foppa C. Infezioni del sistema nervoso. In: Mauro Moroni, Roberto Esposito, Spinello Antinori. Malattie Infettive. VIII a ed. Masson; 2014, p 667-765. ISBN: 9788821439728
9-G.Gaiera, R.Novati, C. Uberti-Foppa. Infezioni sistemiche. In: Claudio Rugarli. Medicina Interna Sistematica. VI a ed. Masson; 2010, p 1891-1956. ISBN: 9788821431098
8-A.Castagna, R.Novati, C. Uberti-Foppa. Infezioni in situazioni particolari. In: Claudio Rugarli. Medicina Interna Sistematica. VI Ia ed. Masson; 2010, p 1973-1993. ISBN: 9788821431098
7-Esposito R., Uberti-Foppa C. Infezioni del sistema nervoso. In: Mauro Moroni, Roberto Esposito. Malattie Infettive. VII a ed. Masson; 2008. ISBN: 9788821439728
6-Caterina Uberti-Foppa. Febbre di origine sconosciuta. In: Lazzarin A, Andreoni M, Angarano G, Carosi G, Di Perri G, Sagnelli E. Malattie Infettive. Casa Editrice Ambrosiana; 2008, p 683-690. Isbn 978-8808-18416-0
5-Lazzarin A, Uberti-Foppa C .Patologia infettiva in gravidanza. In Ferrari GF, Frigerio LG.Manuale di Ginecologia e Ostetricia. Mc Graw Hill; 2004, p 401-413. ISBN: 9788838639708
4-Esposito R., Uberti-Foppa C. Infezioni del sistema nervoso. In: Mauro Moroni, Roberto Esposito. Malattie Infettive. VI a ed. Masson; 2003. ISBN: 9788821439728
3-R.Novati, C. Uberti-Foppa, G Gaiera. Le infezioni sistemiche. In: Claudio Rugarli. Medicina Interna Sistematica. IV a ed. Masson; 2000, p 1473-1534. ISBN: 9788821431098
2-C. Uberti-Foppa. Patologia Infettiva dell’apparato respiratorio. In: Claudio Rugarli. Medicina Interna Sistematica. IV a ed. Masson; 2000, p 1395-1405. ISBN: 9788821431098
1-Esposito R., Uberti-Foppa C. Infezioni del sistema nervoso. In: Mauro Moroni, Roberto Esposito. Malattie Infettive. V a ed. Masson; 1998. ISBN: 9788821439728
Il titolare del presente curriculum vitae, pubblicato online sul portale www.unisr.it, è garante in via esclusiva della correttezza e della veridicità dei dati e delle informazioni in esso riportate e del loro eventuale e puntuale aggiornamento. Egli è dunque il diretto ed unico responsabile dei contenuti indicati nei propri curricula.